ALLK: Allakos Inc Company Short-Term Debt
Allakos Inc. (ALLK) is currently burning through its existing capital according to schedule following the update of its research pipeline, with liquidity standing at 0.00. The company develops antibodies for the treatment of inflammation and allergies within dermatology and gastroenterology. Historical price action clearly demonstrates the asset's market trends. The operating model relies on full outsourcing of production and testing, which shields the scientific staff from heavy capital expenditures.
Metric breakdowns and analytics for Allakos Inc (ALLK)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Allakos Inc.|ALLK - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Allakos Therapeutics|ALLK - Company Total Debt|Debt to Book Capitalization Ratio Allakos Inc.|ALLK - Company Long-Term Liabilities|Company Current Liabilities Allakos|Quick Liquidity allakos.com
- net income and valuation multiples indicators:
Initial company analysis:ALLK - allakos.com
For Allakos Inc., as a biotech company without commercial products, the short-term debt trend serves as an indicator of financial stability during the clinical trial period. This metric aggregates all obligations with a maturity of up to one year, allowing for an assessment of liquidity risk and the probability of a cash crunch before regulatory approvals are obtained and actual cash flow is generated.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities PHVS|Company Short-Term Debts abcellera.com|Company Short-Term Debt Tourmaline Bio, Inc. (TRML)|precigen.com - Company Short-Term Indebtedness|Company Short-Term Debts PHAR (Pharming Group)|Nektar Therapeutics Inc (NKTR) - Short-Term Debt|Upstream Bio Corp - Company Short-Term Debts|ZBIO - Company Short-Term Debts|Immunome, Inc. (IMNM) - Company Short-Term Debt|GOSS (gossamerbio.com) - Company Short-Term Debt|Company Short-Term Debt KalVista Pharmaceuticals, Inc.|Company Short-Term Debt SEPN|Company Short-Term Debts PVLA|Company Short-Term Debts Savara Pharma (SVRA)|Company Short-Term Debt Rigel Pharmaceuticals RIGL|Company Short-Term Debts anaptysbio.com ANAB|ATXS - Company Short-Term Debt|Short-Term Debt enGene Holdings Inc|RAPT Therapeutics (RAPT) - Company Short-Term Debt|JBIO - Short-Term Debt Volume|Company Current Liabilities ACRS|KYTX: Company Short-Term Loans and Borrowings|Company Short-Term Debts TLSA|Short-Term Debt Volume Cabaletta Bio Inc.|Company Short-Term Debt Ventyx Bio VTYX|THTX: Company Short-Term Indebtedness|Avalo Therapeutics, Inc - Company Short-Term Debts|eledon.com (ELDN) - Company Current Liabilities|AGEN (Agenus Inc.) - Company Current Liabilities|CLYM - Short-Term Debt Volume|ZURA (Zura Bio) - Company Short-Term Debts|Company Short-Term Debts aTyr Pharmaceuticals|Company Short-Term Debt Adagene (ADAG)|Company Short-Term Debt IMA (ikenaoncology.com)|Company Short-Term Debt Shattuck Labs STTK|Equillium Inc - Company Short-Term Debt|CNTB - Company Short-Term Debt|IMUX - Company Short-Term Debts|atarabio.com (ATRA) - Company Short-Term Debt|Current Liabilities IFRX (InflaRx)|XFOR (X4 Pharmaceuticals, Inc.) - Company Short-Term Debts|ACET: Company Short-Term Loans and Borrowings|Company Short-Term Debts CELU|Company Short-Term Debts INmune Bio Corporation (INMB)|Company Short-Term Debt Barinthus Biotherapeutics BRNS|Company Short-Term Loans and Borrowings KZR|SABS - Company Short-Term Debt|Akari Therapeutics PLC (AKTX) - Company Current Liabilities|ENLV: Company Short-Term Debts|Q32 Bio (QTTB) - Company Short-Term Debts|Company Current Liabilities GOVX|EDSA: Company Short-Term Loans and Borrowings|Company Short-Term Debts IBIO|Short-Term Debt Volume carismatx.com|Company Short-Term Debt XTL Biopharmaceuticals, Ltd. XTLB|BOLT - Company Current Liabilities|HCWB - Company Short-Term Debt|Aptevo Therapeutics (APVO) - Company Current Liabilities|AIM (AIM ImmunoTech Inc.) - Company Current Liabilities|Aditxt, Inc. (ADTX) - Company Short-Term Debts|Company Short-Term Debt GRI Bio Corp|Company Short-Term Indebtedness XRTX (XORTX Corp)|Company Short-Term Debts HIND|REVB - Short-Term Debt|Company Short-Term Debts INDP (Indaptus Therapeutics, Inc.)|Company Short-Term Debts Scinai Immunotherapeutics Ltd SCNI|CALI - Company Short-Term Debt|AFMD: Company Short-Term Debt|hookipapharma.com (HOOK) - Company Short-Term Debt|IGMS (IGM Biosciences) - Company Short-Term Debt|ITOS (iTeos Therapeutics, Inc.) - Company Short-Term Debts|Company Short-Term Debts Ocean Biomedical Inc|Company Short-Term Debt TC BioPharm (Holdings) PLC (TCBP)|Company Short-Term Debts Third Harmonic Bio Inc (THRD)